UBS AG is offering Buffer Callable Contingent Yield Notes priced at $1,000.00 each and linked to the least-performing of three indexes. Investors should note that the securities are not bank deposits, lack FDIC or other government insurance, and remain subject to preliminary terms that may change before final delivery.
Key Highlights
- UBS AG’s notes carry a public issue price of $1,000 per note.
- Underwriting discounts are $0.00, while proceeds to UBS AG are $1,000 per note.
- The securities are due September 27, 2029 and track the least-performing linked index.
UBS AG is offering Buffer Callable Contingent Yield Notes priced at $1,000 per note and tied to the weakest performer among the S&P 500 Index, Russell 2000 index and Nasdaq-100 Technology Sector Index. The securities are scheduled to mature on September 27, 2029.
The public issue price is $1,000 for each note. UBS AG is allocating $0.00 per note to Underwriting discounts, leaving proceeds of $1,000 per note. UBS Securities LLC and UBS Investment Bank are identified in connection with the offering. The accompanying product supplement, index supplement and prospectus are dated February 6, 2025. References to UBS in the materials apply to UBS AG rather than its consolidated subsidiaries. The notes are not bank deposits.
Preliminary Terms Govern Investor Decisions
The materials state that the current information is incomplete and may be revised. UBS AG describes the securities as Buffer Callable Contingent Yield Notes.
FAQs
Q: What is UBS AG offering at $1,000?
A: UBS AG is offering Buffer Callable Contingent Yield Notes with a $1,000 public issue price per note. The securities are linked to three indexes.
Q: Which indexes are linked to the UBS AG notes?
A: The notes reference the S&P 500 Index, Russell 2000 Index and Nasdaq-100 Technology Sector Index. Their linked outcome is based on the least-performing index.
Q: When do the UBS AG notes mature?
A: The notes are due on September 27, 2029. They are not bank deposits and do not carry FDIC or other government-agency insurance.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.